For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250919:nRSS9405Za&default-theme=true
RNS Number : 9405Z Inspiration Healthcare Group PLC 19 September 2025
19 September 2025
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Board Change
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces that Liz Shanahan, Non-Executive Director, has informed
the Board that she will retire from the Board on 20 November 2025 at the end
of the meeting scheduled to be held on that day. The Company does not intend
to replace this position but will instead keep the composition of the Board
under review. Richard Jones has agreed to take over as Chair of the
Remuneration Committee following Liz's departure.
Roy Davis, Chair, said: "On behalf of the Board, I would like to thank Liz for
her dedication and commitment to Inspiration Healthcare throughout her time on
the Board. We wish Liz every success in her future endeavours."
For further information, please contact:
Inspiration Healthcare Group plc Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer
Panmure Liberum (Nominated Adviser & Broker) Tel: +44 (0)20 3100 2000
Emma Earl
Will Goode
Mark Rogers
Walbrook PR Ltd (Media and Investor Relations) Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
(mailto:inspirationhealthcare@walbrookpr.com)
Anna Dunphy Mob: +44 (0) 7876 741 001
Rachel Broad Mob: +44 (0) 7747 515 393
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.
The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy. In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.
The Company operates in the UK from its Manufacturing and Technology Centre in
Croydon, South London, and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABSGDCXUBDGUI